• Setup menu at Appearance » Menus and assign menu to Top Bar Navigation
Monday, April 19, 2021
No Result
View All Result
The Hub Press
  • Top News
  • World
  • Politics
  • Business
  • Sports
  • Travel
  • Health
  • News TV
  • Lifestyle
  • Science
  • Entertainment
  • Top News
  • World
  • Politics
  • Business
  • Sports
  • Travel
  • Health
  • News TV
  • Lifestyle
  • Science
  • Entertainment
No Result
View All Result
The Hub Press
No Result
View All Result
Home Top News

J&J to begin human trials of COVID-19 vaccine in second half of July

by Thehub Press
June 10, 2020
in Top News
0
J&J to begin human trials of COVID-19 vaccine in second half of July
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter


The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., May 29, 2019. REUTERS/Brendan McDermid

(Reuters) – Johnson & Johnson said on Wednesday it would start human trials of its potential COVID-19 vaccine in the second half of July.

Reporting by Saumya Sibi Joseph in Bengaluru; Editing by Saumyadeb Chakrabarty

Our Standards:The Thomson Reuters Trust Principles.



CNN

Tags: Company NewsContent produced in BangaloreCoronavirusHealthHealth / MedicineHealthcare (TRBC)Infectious diseasesJOHNSONMajor NewsPharmaceuticals (TRBC)Pharmaceuticals and Medical Research (TRBC)United StatesUSVaccines
Thehub Press

Thehub Press

Next Post
UPADEK KABAŁY -FALL OF THE KABALA

UPADEK KABAŁY -FALL OF THE KABALA

Recommended

No Content Available




  • Top News
  • World
  • Politics
  • Business
  • Sports
  • Travel
  • Health
  • News TV
  • Lifestyle
  • Science
  • Entertainment

© 2019 Thehub.Press

No Result
View All Result
  • Top News
  • World
  • Politics
  • Business
  • Sports
  • Travel
  • Health
  • News TV
  • Lifestyle
  • Science
  • Entertainment

© 2019 Thehub.Press